Neuroscience and accelerator mass spectrometry

Journal of Mass Spectrometry

Volumn 40, Issue 2, 2005, Pages 154-159

  Palmblad, Magnus ^a   Buchholz, Bruce A ^a   Hillegonds, Darren J ^a   Vogel, John S ^a  

^a LAWRENCE LIVERMORE NATIONAL LABORATORY   (United States)

Author keywords

Accelerator mass spectrometry; Alzheimer's disease; Carbon 14; Diisopropyl fluorophosphate; Radiocarbon

Indexed keywords

BIOMEDICAL ENGINEERING; BLOOD; BRAIN; DRUG PRODUCTS; GEOCHRONOLOGY; MOLECULAR DYNAMICS; NEUROLOGY; RADIOISOTOPES; TOXICITY;

ACCELERATOR MASS SPECTROMETRY (AMS); ARCHAEOLOGY; BIOMOLECULAR INTERACTIONS; NEUROTOXICOLOGY;

MASS SPECTROMETRY;

ALUMINUM 26; CALCIUM; CALCIUM 41; CARBON 14; CHLORINE 36; ISOTOPE; NEUROTOXIN; TRITIUM; UNCLASSIFIED DRUG;

ACCELERATOR MASS SPECTROSCOPY; ACCURACY; ARTICLE; BIOAVAILABILITY; BLOOD BRAIN BARRIER; HUMAN; MASS SPECTROMETRY; MATRIX ENHANCED SECONDARY ION MASS SPECTROMETRY; MOLECULAR INTERACTION; NEUROSCIENCE; NEUROTOXICITY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SENSITIVITY AND SPECIFICITY;

AGE FACTORS; ALZHEIMER DISEASE; ANIMALS; BLOOD-BRAIN BARRIER; BRAIN CHEMISTRY; CARBON RADIOISOTOPES; HUMANS; INSECTICIDES; ISOFLUROPHATE; ISOTOPE LABELING; MASS SPECTROMETRY; NEUROSCIENCES; PARTICLE ACCELERATORS;

EID: 14744276329     PISSN: 10765174     EISSN: None     Source Type: Journal    
DOI: 10.1002/jms.734     Document Type: Article

References (55)

1. Adelstein SJ, Manning FJ. Isotopes for Medicine and the Life Sciences. National Academy Press, Washington, DC: 1995.
2. Dalvie D. Recent advances in the applications of radioisotopes in drug metabolism, toxicology and pharmacokinetics. Curr. Pharm. Des. 2000; 6: 1009.
3. Turteltaub KW, Vogel JS. Bioanalytical applications of accelerator mass spectrometry for pharmaceutical research. Curr. Pharm. Des. 2000; 6: 991.
4. Ognibene TJ, Amer H, Benjamin KR, Bench G, Vogel JS, Colvin ME. A protocol for the quantitative determination of biomolecules in individual cells. In preparation.
5. Gilman SD, Gee SJ, Hammock BD, Vogel JS, Haack K, Buchholz BA, Freeman SPHT, Wester RC, Hui XY, Maibach HI. Analytical performance of accelerator mass spectrometry and liquid scintillation counting for detection of C-14-labeled atrazine metabolites in human urine. Anal. Chem. 1998; 70: 3463.
6. Vogel JS, McAninch J, Freeman SPHT. Elements in biological AMS. Nucl. Instrume. Methods Phys. Res. B 1997; 123: 241.
7. Yokel RA, McNamara PJ. Aluminium toxicokinetics: an updated minireview. Pharmacol. Toxicol. 2001; 88: 159.
8. Vogel JS, Southon JR, Nelson DE, Brown TA. Performance of catalytically condensed carbon for use in accelerator mass-spectrometry. Nucl. Instrume. Methods Phys. Res. B 1984; 233: 289.
9. Vogel JS. Rapid Production of graphite without contamination for biomedical AMS. Radiocarbon 1992; 34: 344.
10. 2 obtained from biochemical samples to graphite in septa-sealed vials for quantification of C-14 via accelerator mass spectrometry. Anal Chem. 2003; 75: 2192.
11. Vogel JS, Grant PG, Buchholz BA, Dingley K, Turteltaub KW. Attomole quantitation of protein separations with accelerator mass spectrometry. Electrophoresis 2001; 22: 2037.
12. Buchholz BA, Fultz E, Haack KW, Vogel JS, Gilman SD, Gee SJ, Hammock BD, Hui X, Wester RC, Maibach HI. HPLC-accelerator MS measurement of atrazine metabolites in human urine after dermal exposure. Anal. Chem. 1999; 71: 3519.
13. Shan G, Huang W, Gee SJ, Buchholz BA, Vogel JS, Hammock BD. Isotope-labeled immunoassays without radiation waste. Proc. Natl. Acad. Sci. USA 2000; 97: 2445.
14. Steen H, Pandey A. Proteomics goes quantitative: measuring protein abundance. Trends Biotechnol. 2002; 20: 361.
15. Lill J. Proteomic tools for quantitation by mass spectrometry. Mass Spectrom Rev. 2003; 22: 182.
16. Ognibene TJ, Bench G, Brown TA, Peaslee GF, Vogel JS. A new accelerator mass spectrometry system for C-14-quantification of biochemical samples. Int. J. Mass Spectrom. 2002; 218: 255.
17. Nydal R, Lövseth K. Distribution of radiocarbon from nuclear tests. Nature 1971; 232: 418.
18. Levin I, Kromer B, Schochfischer H, Bruns M, Munnich M, Berdau D, Vogel JC, Munnich KO. 25 years of tropospheric C-14 observations in central Europe. Radiocarbon 1985; 27: 1.
19. Levin I, Bösinger R, Bonani G, Francey RJ, Kromer B, Munnich KO, Suter M, Trivett NBA, Wölfli W. In Radiocarbon after Four Decades: an Interdisciplinary Perspective, RE Taylor, A Long, RS Kra. (eds). Springer: New York, 1992; 503.
20. Druffel EM, Mok HYI. Time history of human gallstones-application of the post-bomb radiocarbon signal. Radiocarbon 1983; 25: 629.
21. Mok HYI, Druffel ERM, Rampone WM. Chronology of cholelithiasis-dating gallstones from atmospheric radiocarbon produced by nuclear bomb explosions. N. Engl. J. Med. 1986; 314: 1075.
22. Broecker WS, Schulert A, Olson EA. Bomb 14C in human beings. Science 1959; 130: 331.
23. Harkness DD, Walton A. Further investigations of the transfer of bomb 14C to man. Nature 1972; 240: 302.
24. Stenhouse MJ, Baxter MS. Bomb C-14 as a biological tracer. Nature 1977; 267: 828.
25. Grant PG, Palmblad M, Murov S, Hillegonds DJ, Ueda DL, Vogel JS, Bench G. Alpha-particle energy loss measurement of microgram depositions of biomolecules. Anal. Chem. 2003; 75: 4519.
26. Lowndes HE, Baker T, Riker WF Jr. Motor nerve terminal response to edrophonium in delayed DFP neuropathy. Eur. J. Pharmacol. 1975; 30: 69.
27. Ferrer O. Clinical evaluation of DFP (diisopropyl fluorophosphate) in glaucoma. Arch. Hosp. Univ. 1950; 2: 675.
28. Holland MG. Autonomic drugs in ophthalmology: some problems and promises. I. Directly and indirectly acting parasympathomimetic drugs. Ann. Ophthalmol. 1974; 6: 447.
29. Rosenstock L, Keifer M, Dardell WE, McConnell R, Claypoole K. Chronic central nervous system effects of acute organophosphate pesticide intoxication. The Pesticide Health Effects Study Group. Lancet 1991; 338: 223.
30. Senanayake N, Karalliedde L. Neurotoxic effects of organophosphorus insecticides. An intermediate syndrome. N. Engl. J. Med. 1987; 316: 761.
31. Prendergast MA, Terry AV Jr, Buccafusco JJ. Effects of chronic, low-level organophosphate exposure on delayed recall, discrimination, and spatial learning in monkeys and rats. Neurotoxicol. Teratol. 1998; 20: 115.
32. Stone JD, Terry AV Jr, Pauly JR, Prendergast MA, Buccafusco JJ. Protractive effects of chronic treatment with an acutely subtoxic regimen of diisopropylflurophosphate on the expression of cholinergic receptor densities in rats. Brain Res. 2000; 882: 9.
33. Vogel JS, Keating GA II, Buchholz BA. Protein binding of isofluorophate in vivo after coexposure to multiple chemicals. Environ. Health Perspect. 2002; 110(Suppl 6): 1031.
34. AAALAC guideline, http://www.aaalac.org/guide.htm.
35. Abou-Donia MB, Goldstein LB, Jones KH, Abdel-Rahman AA, Damodaran TV, Dechkovskaia AM, Bullman SL, Amir BE, Khan WA. Locomotor and sensorimotor performance deficit in rats following exposure to pyridostigmine bromide, DEET, and permethrin, alone and in combination. Toxical. Sci. 2001; 60: 305.
36. Vogel JS, Hillegonds DJ, Palmblad M, Grant PG, Bench G. In Methods in Proteome and Protein Analysis, Kamp RM, Calvete JJ, Choli-Papadopoulou. (eds). Springer: Heidelberg, 2004; 203.
37. Hillegonds DJ, Palmblad M, Grant PG, Bench G, Buchholz BA, Keating G, Vogel JS. In Synthesis and Applications of Isotopically Labeled Compounds, Dean DC, Filer CN, McCarthy KE. (ed.). Wiley: New York, 2004.
38. Buchholz BA, Pawley NH, Vogel JS, Mauthe RJ. Pyrethroid decrease in central nervous system from nerve agent pretreatment. J. Appl. Toxicol. 1997; 17: 231.
39. Cummings JL. Toward a molecular neuropsychiatry of neurodegenerative diseases. Ann. Neurol. 2003; 54: 147.
40. Selkoe DJ, Lansbury PT. In Basic Neurochemistry: Molecular, Cellular and Medical Aspects, GJ Siegel, BW Agravoff, RG Albers, SK Fisher, MD Uhler. (eds). Lippincott Williams and Wilkins: Philadelphia, 1999; 950-964.
41. Jellinger KA. Neuropathological spectrum of synucleinopathies. Mov. Disord. 2003; 18(Suppl. 6): S2.
42. McKeith I, Mintzer J, Aarsland D, Burn D, Chiu H, Cohen-Mansfield J, Dickson D, Dubois B, Duda JE, Feldman H, Gauthier S, Halliday G, Lawlor B, Lippa C, Lopez OL, Carlos Machado J, O'Brien J, Playfer J, Reid W. Dementia with Lewy bodies. Lancet Neurol. 2004; 3: 19.
43. Lovell MA, Robertson JD, Buchholz BA, Xie C, Markesbery WR. Use of bomb pulse carbon-14 to age senile plaques and neurofibrillary tangles in Alzheimer's disease. Neurobiol. Aging 2002; 23: 179.
44. Vogel JS, Southern JR, Nelson DE. Nucl. Instrume. Methods Phys. Res. B 1987; 29: 50.
45. Yokel RA, Rhineheimer SS, Sharma P, Elmore D, McNamara PJ. Entry, half-life, and desferrioxamine-accelerated clearance of brain aluminum after a single (26)A1 exposure. Toxicol. Sci. 2001; 64: 77.
46. Yokel RA. Brain uptake, retention, and efflux of aluminum and manganese. Environ. Health Perspect. 2002; 110(Suppl. 5): 699.
47. Zucker RS. Calcium- and activity-dependent synaptic plasticity. Curr. Opin. Neurobiol. 1999; 9: 305.
48. Sjöström PJ, Nelson SB. Spike timing, calcium signals and synaptic plasticity. Curr. Opin. Neurobiol. 2002; 12: 305.
49. Sin WC, Haas K, Ruthazer ES, Cline HT. Dendrite growth increased by visual activity requires NMDA receptor and Rho GTPases. Nature 2002; 419: 475.
50. Maletic-Savatic M, Malinow R, Svoboda K. Rapid dendritic morphogenesis in CA1 hippocampal dendrites induced by synaptic activity. Science 1999; 283: 1923.
51. Sabatini BL, Maravall M, Svoboda K. Ca(2+) signaling in dendritic spines. Curr. Opin. Neurobiol. 2001; 11: 349.
52. Yasuda R, Nimchinsky EA, Scheuss V, Pologruto TA, Oertner TG, Sabatini BL, Svoboda K. Imaging calcium concentration dynamics in small neuronal compartments. Sci. STKE. 2004; 2004: 15.
53. 41Ca by accelerator mass spectrometry to quantitate small changes in individual human bone turnover rates. J. Assoc. Lab. Autom. 2004; 9: 99.
54. 2)-C-14 observations at Schauinsland station, Germany. Radiocarbon 1997; 39: 205.
55. Nachon F, Nicolet Y, Viguie N, Masson P, Fontecilla-Camps JC, Lockridge O. Engineering of a monomeric and low-glycosylated form of human butyrylcholinesterase-expression, purification, characterization and crystallization. Eur. J. Biochem. 2002; 269: 630.